IGF2BP1 was reported to be associated with lipid accumulation in macrophages or serve as a biomarker for NSCLC; however, the relationship between IGF2BP1 and fatty acid metabolism in LUAD had not been shown (Kato et al., 2007; Liu et al., 2022). Here, IGF2BP1 is linked to non-small cell lung carcinoma.